Low Grade Neuroendocrine Tumors of the Lung
Abstract
The lung is the second most common site of neuroendocrine tumors (NETs). Typical and atypical carcinoids are low-grade NETs of the lung. They present a favorable prognosis comported to the more common high-grade NETs.
The low- and high-grade NETs require different treatment strategies; effective management of these tumors is essential to prolong survival and to manage the symptoms in patients with secretory or functional tumors.
These rare tumors have received little attention and education is needed for treating physicians.
This mini-review will concentrate mainly on advanced low-grade lung NETs.
The article describes the classification of lung NETs and the diagnostic work-up.
Different treatment methods including somatostatin analogs, peptide receptor radioligand therapy, and biologic systemic therapy are discussed.
Promising results from recent trials are presented and discussed in the context of the lung primary site.
See also:
- Somatostatin in oncology, the overlooked evidences;
- The Di Bella Method (A Fixed Part - Cyclophosphamide and/or Hydroxyurea tablets, one or two per day);
- Pancreatic Adenocarcinoma: clinical records on 17 patients treated with Di Bella's Method;